Cart
sales@molnova.com
AS-1763
CAS No. 2227211-00-7
AS-1763( —— )
Catalog No. M35144 CAS No. 2227211-00-7
AS-1763 is an orally available and selective BTK inhibitor with an IC50 of 0.85 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 553 | In Stock |
|
| 10MG | 827 | In Stock |
|
| 25MG | 1416 | In Stock |
|
| 50MG | 2074 | In Stock |
|
| 100MG | 3116 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAS-1763
-
NoteResearch use only, not for human use.
-
Brief DescriptionAS-1763 is an orally available and selective BTK inhibitor with an IC50 of 0.85 nM.
-
DescriptionAS-1763 is an orally available and selective BTK inhibitor with an IC50 of 0.85 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetBTK
-
RecptorBTK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2227211-00-7
-
Formula Weight578.64
-
Molecular FormulaC33H31FN6O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=2C(F)=CC(=CC2C=CN1C3=CC=CC(C=4N=C(N=C5NC(=CC54)C6=CCN(CC6)C7COC7)N)=C3CO)C8CC8
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
TAK-020
TAK-020 is a potent covalent inhibitor of Btk with potential antitumor activity for the study of rheumatoid arthritis and immune-related diseases.
-
AVL-292
AVL-292 (Spebrutinib, CC-292) is a highly selective, covalent Btk inhibitor with IC50 of <1 nM; also less potently inhibits Yes, c-Src, Brk, Lyn, and Fyn with IC50s of 723 nM, 1.729 uM, 2.43 uM, 4.4 uM, and 7.15 uM, rspectively.
-
(±)-Zanubrutinib
The active enantiomer of Zanubrutinib (BGB3111), a potent, selective and orally available Btk inhibitor.
